Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sparta's i.v. formulation of busulfan enters phase I

March 25, 1997

Tokyo University researchers characterize new steroidal saponin

March 25, 1997

Daiichi discloses new antitumor agents

March 25, 1997

Preliminary phase I results for annamycin

March 21, 1997

Targretin enters phase II for diabetes

March 21, 1997

Matrix files NDA ammendment for AccuSite

March 21, 1997

U.S. researchers discover protein that inhibits apoptosis

March 21, 1997

Tumor-suppressing gene identified by scientists at Northwest Hospital

March 20, 1997

Antitumor/antiviral distamycin derivatives from P&U

March 19, 1997

Corixa and SmithKline Beecham collaborate on vaccine research

March 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.